The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1
ABSTRACT The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) ha...
Gespeichert in:
Veröffentlicht in: | Journal of bone and mineral research 2017-10, Vol.32 (10), p.2103-2115 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2115 |
---|---|
container_issue | 10 |
container_start_page | 2103 |
container_title | Journal of bone and mineral research |
container_volume | 32 |
creator | McMichael, Brooke K Jeong, Yong‐Hoon Auerbach, Justin A Han, Cheol‐Min Sedlar, Ryan Shettigar, Vikram Bähler, Martin Agarwal, Sudha Kim, Do‐Gyoon Lee, Beth S |
description | ABSTRACT
The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research |
doi_str_mv | 10.1002/jbmr.3192 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1906466743</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1950412972</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</originalsourceid><addsrcrecordid>eNp10L1OwzAUBWALgWgpDLwAssQCQ1r_xI4zAoJSREVVdWGK4uSapkriYqegbjwCz8iTkFJgQGI6y6ejew9Cx5T0KSFssNCV63Masx3UpYLxIJSK7qIuUSoMSMhpBx14vyCESCHlPuowJZSQseiix9kc8HRuhxcTPF7bWOOJs5VtwONLWwMeOvvazLFe4zHkRdoU9RN-8A1YXaa-KTI8Bb-0tS9eoAbvcWPxaHjz8fZOD9GeSUsPR9_ZQ7Ob69nVbXD_MBxdXdwHGVeKBUykQKOM85QoI9p3iI7ayHVmpFE6zgAIMVrFxgAnRuQ8p2kGOsqZEDTmPXS2rV06-7wC3yRV4TMoy7QGu_IJjYkMpYxC3tLTP3RhV65uj2uVICFlccRadb5VmbPeOzDJ0hVV6tYJJclm7mQzd7KZu7Un340rXUH-K3_2bcFgC16LEtb_NyV3l-PpV-Un7LKJug</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950412972</pqid></control><display><type>article</type><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</creator><creatorcontrib>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</creatorcontrib><description>ABSTRACT
The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</description><identifier>ISSN: 0884-0431</identifier><identifier>EISSN: 1523-4681</identifier><identifier>DOI: 10.1002/jbmr.3192</identifier><identifier>PMID: 28585695</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Actin ; Age ; Animals ; Biomechanical Phenomena ; Bone Development - drug effects ; Bone growth ; Bone morphogenetic protein 2 ; BONE QCT/μCT ; Cancellous Bone - metabolism ; Cancellous Bone - pathology ; Cancellous Bone - physiopathology ; Cell Adhesion ; Cell culture ; Cell Line ; Cell migration ; Chemotaxis ; Females ; Femur - metabolism ; Femur - pathology ; Femur - physiopathology ; Fibers ; Gene expression ; Gene Knockdown Techniques ; GH/IGF‐1 ; Growth rate ; Guanine ; Guanosine ; Guanosine triphosphatases ; Heterozygotes ; Insulin-like growth factor I ; Insulin-Like Growth Factor I - pharmacology ; Mechanotransduction ; Mice, Inbred C57BL ; Mice, Knockout ; MOLECULAR PATHWAYS–DEVELOPMENT ; Myosins - deficiency ; Myosins - metabolism ; Nuclei ; OSTEOBLASTS ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Osteoclasts ; Osteogenesis ; OSTEOPOROSIS ; Platelet-derived growth factor ; Puberty ; Rats ; Sexual Maturation</subject><ispartof>Journal of bone and mineral research, 2017-10, Vol.32 (10), p.2103-2115</ispartof><rights>2017 American Society for Bone and Mineral Research</rights><rights>2017 American Society for Bone and Mineral Research.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</citedby><cites>FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjbmr.3192$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjbmr.3192$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28585695$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McMichael, Brooke K</creatorcontrib><creatorcontrib>Jeong, Yong‐Hoon</creatorcontrib><creatorcontrib>Auerbach, Justin A</creatorcontrib><creatorcontrib>Han, Cheol‐Min</creatorcontrib><creatorcontrib>Sedlar, Ryan</creatorcontrib><creatorcontrib>Shettigar, Vikram</creatorcontrib><creatorcontrib>Bähler, Martin</creatorcontrib><creatorcontrib>Agarwal, Sudha</creatorcontrib><creatorcontrib>Kim, Do‐Gyoon</creatorcontrib><creatorcontrib>Lee, Beth S</creatorcontrib><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><title>Journal of bone and mineral research</title><addtitle>J Bone Miner Res</addtitle><description>ABSTRACT
The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</description><subject>Actin</subject><subject>Age</subject><subject>Animals</subject><subject>Biomechanical Phenomena</subject><subject>Bone Development - drug effects</subject><subject>Bone growth</subject><subject>Bone morphogenetic protein 2</subject><subject>BONE QCT/μCT</subject><subject>Cancellous Bone - metabolism</subject><subject>Cancellous Bone - pathology</subject><subject>Cancellous Bone - physiopathology</subject><subject>Cell Adhesion</subject><subject>Cell culture</subject><subject>Cell Line</subject><subject>Cell migration</subject><subject>Chemotaxis</subject><subject>Females</subject><subject>Femur - metabolism</subject><subject>Femur - pathology</subject><subject>Femur - physiopathology</subject><subject>Fibers</subject><subject>Gene expression</subject><subject>Gene Knockdown Techniques</subject><subject>GH/IGF‐1</subject><subject>Growth rate</subject><subject>Guanine</subject><subject>Guanosine</subject><subject>Guanosine triphosphatases</subject><subject>Heterozygotes</subject><subject>Insulin-like growth factor I</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Mechanotransduction</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>MOLECULAR PATHWAYS–DEVELOPMENT</subject><subject>Myosins - deficiency</subject><subject>Myosins - metabolism</subject><subject>Nuclei</subject><subject>OSTEOBLASTS</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Osteoclasts</subject><subject>Osteogenesis</subject><subject>OSTEOPOROSIS</subject><subject>Platelet-derived growth factor</subject><subject>Puberty</subject><subject>Rats</subject><subject>Sexual Maturation</subject><issn>0884-0431</issn><issn>1523-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10L1OwzAUBWALgWgpDLwAssQCQ1r_xI4zAoJSREVVdWGK4uSapkriYqegbjwCz8iTkFJgQGI6y6ejew9Cx5T0KSFssNCV63Masx3UpYLxIJSK7qIuUSoMSMhpBx14vyCESCHlPuowJZSQseiix9kc8HRuhxcTPF7bWOOJs5VtwONLWwMeOvvazLFe4zHkRdoU9RN-8A1YXaa-KTI8Bb-0tS9eoAbvcWPxaHjz8fZOD9GeSUsPR9_ZQ7Ob69nVbXD_MBxdXdwHGVeKBUykQKOM85QoI9p3iI7ayHVmpFE6zgAIMVrFxgAnRuQ8p2kGOsqZEDTmPXS2rV06-7wC3yRV4TMoy7QGu_IJjYkMpYxC3tLTP3RhV65uj2uVICFlccRadb5VmbPeOzDJ0hVV6tYJJclm7mQzd7KZu7Un340rXUH-K3_2bcFgC16LEtb_NyV3l-PpV-Un7LKJug</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>McMichael, Brooke K</creator><creator>Jeong, Yong‐Hoon</creator><creator>Auerbach, Justin A</creator><creator>Han, Cheol‐Min</creator><creator>Sedlar, Ryan</creator><creator>Shettigar, Vikram</creator><creator>Bähler, Martin</creator><creator>Agarwal, Sudha</creator><creator>Kim, Do‐Gyoon</creator><creator>Lee, Beth S</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7TS</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201710</creationdate><title>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</title><author>McMichael, Brooke K ; Jeong, Yong‐Hoon ; Auerbach, Justin A ; Han, Cheol‐Min ; Sedlar, Ryan ; Shettigar, Vikram ; Bähler, Martin ; Agarwal, Sudha ; Kim, Do‐Gyoon ; Lee, Beth S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3882-25ae17c33a08f51000b7510dbcf6f8b9cee00fb89ffe30f5d3d1aceb7d255193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Actin</topic><topic>Age</topic><topic>Animals</topic><topic>Biomechanical Phenomena</topic><topic>Bone Development - drug effects</topic><topic>Bone growth</topic><topic>Bone morphogenetic protein 2</topic><topic>BONE QCT/μCT</topic><topic>Cancellous Bone - metabolism</topic><topic>Cancellous Bone - pathology</topic><topic>Cancellous Bone - physiopathology</topic><topic>Cell Adhesion</topic><topic>Cell culture</topic><topic>Cell Line</topic><topic>Cell migration</topic><topic>Chemotaxis</topic><topic>Females</topic><topic>Femur - metabolism</topic><topic>Femur - pathology</topic><topic>Femur - physiopathology</topic><topic>Fibers</topic><topic>Gene expression</topic><topic>Gene Knockdown Techniques</topic><topic>GH/IGF‐1</topic><topic>Growth rate</topic><topic>Guanine</topic><topic>Guanosine</topic><topic>Guanosine triphosphatases</topic><topic>Heterozygotes</topic><topic>Insulin-like growth factor I</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Mechanotransduction</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>MOLECULAR PATHWAYS–DEVELOPMENT</topic><topic>Myosins - deficiency</topic><topic>Myosins - metabolism</topic><topic>Nuclei</topic><topic>OSTEOBLASTS</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Osteoclasts</topic><topic>Osteogenesis</topic><topic>OSTEOPOROSIS</topic><topic>Platelet-derived growth factor</topic><topic>Puberty</topic><topic>Rats</topic><topic>Sexual Maturation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McMichael, Brooke K</creatorcontrib><creatorcontrib>Jeong, Yong‐Hoon</creatorcontrib><creatorcontrib>Auerbach, Justin A</creatorcontrib><creatorcontrib>Han, Cheol‐Min</creatorcontrib><creatorcontrib>Sedlar, Ryan</creatorcontrib><creatorcontrib>Shettigar, Vikram</creatorcontrib><creatorcontrib>Bähler, Martin</creatorcontrib><creatorcontrib>Agarwal, Sudha</creatorcontrib><creatorcontrib>Kim, Do‐Gyoon</creatorcontrib><creatorcontrib>Lee, Beth S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Physical Education Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bone and mineral research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McMichael, Brooke K</au><au>Jeong, Yong‐Hoon</au><au>Auerbach, Justin A</au><au>Han, Cheol‐Min</au><au>Sedlar, Ryan</au><au>Shettigar, Vikram</au><au>Bähler, Martin</au><au>Agarwal, Sudha</au><au>Kim, Do‐Gyoon</au><au>Lee, Beth S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1</atitle><jtitle>Journal of bone and mineral research</jtitle><addtitle>J Bone Miner Res</addtitle><date>2017-10</date><risdate>2017</risdate><volume>32</volume><issue>10</issue><spage>2103</spage><epage>2115</epage><pages>2103-2115</pages><issn>0884-0431</issn><eissn>1523-4681</eissn><abstract>ABSTRACT
The Ras homolog A (RhoA) subfamily of Rho guanosine triphosphatases (GTPases) regulates actin‐based cellular functions in bone such as differentiation, migration, and mechanotransduction. Polymorphisms or genetic ablation of RHOA and some of its regulatory guanine exchange factors (GEFs) have been linked to poor bone health in humans and mice, but the effects of RhoA‐specific GTPase‐activating proteins (GAPs) on bone quality have not yet been identified. Therefore, we examined the consequences of RhoGAP Myo9b gene knockout on bone growth, phenotype, and cellular activity. Male and female mice lacking both alleles demonstrated growth retardation and decreased bone formation rates during early puberty. These mice had smaller, weaker bones by 4 weeks of age, but only female KOs had altered cellular numbers, with fewer osteoblasts and more osteoclasts. By 12 weeks of age, bone quality in KOs worsened. In contrast, 4‐week‐old heterozygotes demonstrated bone defects that resolved by 12 weeks of age. Throughout, Myo9b ablation affected females more than males. Osteoclast activity appeared unaffected. In primary osteogenic cells, Myo9b was distributed in stress fibers and focal adhesions, and its absence resulted in poor spreading and eventual detachment from culture dishes. Similarly, MC3T3‐E1 preosteoblasts with transiently suppressed Myo9b levels spread poorly and contained decreased numbers of focal adhesions. These cells also demonstrated reduced ability to undergo IGF‐1–induced spreading or chemotaxis toward IGF‐1, though responses to PDGF and BMP‐2 were unaffected. IGF‐1 receptor (IGF1R) activation was normal in cells with diminished Myo9b levels, but the activated receptor was redistributed from stress fibers and focal adhesions into nuclei, potentially affecting receptor accessibility and gene expression. These results demonstrate that Myo9b regulates a subset of RhoA‐activated processes necessary for IGF‐1 responsiveness in osteogenic cells, and is critical for normal bone formation in growing mice. © 2017 American Society for Bone and Mineral Research</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28585695</pmid><doi>10.1002/jbmr.3192</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0884-0431 |
ispartof | Journal of bone and mineral research, 2017-10, Vol.32 (10), p.2103-2115 |
issn | 0884-0431 1523-4681 |
language | eng |
recordid | cdi_proquest_miscellaneous_1906466743 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Oxford University Press Journals All Titles (1996-Current) |
subjects | Actin Age Animals Biomechanical Phenomena Bone Development - drug effects Bone growth Bone morphogenetic protein 2 BONE QCT/μCT Cancellous Bone - metabolism Cancellous Bone - pathology Cancellous Bone - physiopathology Cell Adhesion Cell culture Cell Line Cell migration Chemotaxis Females Femur - metabolism Femur - pathology Femur - physiopathology Fibers Gene expression Gene Knockdown Techniques GH/IGF‐1 Growth rate Guanine Guanosine Guanosine triphosphatases Heterozygotes Insulin-like growth factor I Insulin-Like Growth Factor I - pharmacology Mechanotransduction Mice, Inbred C57BL Mice, Knockout MOLECULAR PATHWAYS–DEVELOPMENT Myosins - deficiency Myosins - metabolism Nuclei OSTEOBLASTS Osteoblasts - drug effects Osteoblasts - metabolism Osteoclasts Osteogenesis OSTEOPOROSIS Platelet-derived growth factor Puberty Rats Sexual Maturation |
title | The RhoGAP Myo9b Promotes Bone Growth by Mediating Osteoblastic Responsiveness to IGF‐1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T03%3A04%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20RhoGAP%20Myo9b%20Promotes%20Bone%20Growth%20by%20Mediating%20Osteoblastic%20Responsiveness%20to%20IGF%E2%80%901&rft.jtitle=Journal%20of%20bone%20and%20mineral%20research&rft.au=McMichael,%20Brooke%20K&rft.date=2017-10&rft.volume=32&rft.issue=10&rft.spage=2103&rft.epage=2115&rft.pages=2103-2115&rft.issn=0884-0431&rft.eissn=1523-4681&rft_id=info:doi/10.1002/jbmr.3192&rft_dat=%3Cproquest_cross%3E1950412972%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1950412972&rft_id=info:pmid/28585695&rfr_iscdi=true |